Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New PTK inhibitors developed at Bristol-Myers Squibb

June 15, 1999

FDA approves initiation of clinical trial of strep vaccine

June 15, 1999

Japanese lab discloses inhibitors of STAT6 activation

June 14, 1999

Amrad reports disappointing results of phase II trial evaluating RSV vaccine

June 11, 1999

Tresperimus for the treatment of GvHD in bone marrow transplant recipients

June 10, 1999

Accelerated vaccination schedule effective for Lyme disease

June 10, 1999

Inhibitex obtains license to MSCRAMM from University of Minnesota

June 8, 1999

New bone marrow transplant technique looks promising

June 8, 1999

Fludarabine and other specific STAT1-targeting drugs as potential immunosuppressants

June 7, 1999

Wyeth Lederle Vaccines submits PLA for pneumococcal vaccine

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...